-
Cervical Cancer: A Global Challenge
Low- and middle-income countries make inroads against a preventable and treatable cancer.
by Erin O’Donnell
-
Q&A
The FDA’s Risk-Benefit FrameworkUsing the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
Get Involved
Healing Takes FlightAlicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Making Informed Consent Accessible
Confusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Patient and Doctor Partnerships
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors.
by Karon Warren
-
Exploring a New Frontier
AACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Get Involved
The Power of PlayPediatric cancer survivor Eric Newman launched the Roc Solid Foundation, which builds playsets for children who have cancer.
by Thomas Celona
-
Policy Matters
A Call to Eliminate InequitiesThe AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
by Lisa A. Newman, MD, MPH
-
Cultural Competence in the Community
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles